Application of New Magnetic Resonance UTE Technique in Hip Joint Lesions

Application of New Magnetic Resonance Technique-UTE in Hip Joint Lesions

Explore the imaging and quantitative monitoring of hip bone, cartilage and ligament by magnetic resonance UTE technology, combined with QCT and DXA technology, to provide a more accurate basis for clinical evaluation and treatment.

Study Overview

Status

Recruiting

Conditions

Detailed Description

Osteoporosis is a systemic bone metabolism-related disease characterized by decreased bone mass per unit volume, increased bone fragility, decreased bone density, thinning of the bone cortex and changes in bone microstructure. It often occurs in the lumbar spine and hip joint. Femoral neck fracture is a common complication of hip osteoporosis, which seriously affects people's quality of life. UTE technology can clearly image and quantify human cortical bone and cancellous bone, and advanced UTE technology such as STAIR-UTE and UTE-MT have made some progress in the field of osteoporosis. The purpose of this study was to explore UTE technology for imaging and quantitative study of cortical bone, cancellous bone and cartilage of hip joint, and to find more accurate imaging methods for clinical evaluation of hip osteoporosis and other diseases.

Study Type

Observational

Enrollment (Estimated)

150

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Guangdong
      • Zhuhai, Guangdong, China, 519000
        • Recruiting
        • Radiography department
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients who meet the inclusion criteria

Description

Inclusion Criteria:

  1. Patients with past or suspected osteoporosis and bone loss;
  2. Patients with previous femoral neck fracture;
  3. Patients with avascular necrosis of femoral head;
  4. Hip osteoarthritis patients.

Exclusion Criteria:

  1. Patients with metal implants in corresponding parts;
  2. Claustrophobic.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
normal group
There are no lesions on the hip.
abnormal group
There are some lesions on the hip.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
proton density fat fraction (PDFF)
Time Frame: Baseline (before surgery)
Magnetic resonance proton density fat fraction
Baseline (before surgery)
T2 relaxation rate
Time Frame: Baseline (before surgery)
R2*
Baseline (before surgery)
Magnetization Transfer Ratio (MTR)
Time Frame: Baseline (before surgery)
magnetization transfer ratio
Baseline (before surgery)
T1rho
Time Frame: Baseline (before surgery)
spin-lattice relaxation in the rotation ame
Baseline (before surgery)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subjective rating values
Time Frame: Baseline (before surgery)
rating values
Baseline (before surgery)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Shaolin Li, Fifth Affiliated Hospital, Sun Yat-Sen University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2023

Primary Completion (Estimated)

June 13, 2024

Study Completion (Estimated)

June 13, 2024

Study Registration Dates

First Submitted

August 2, 2023

First Submitted That Met QC Criteria

August 17, 2023

First Posted (Actual)

August 21, 2023

Study Record Updates

Last Update Posted (Actual)

August 21, 2023

Last Update Submitted That Met QC Criteria

August 17, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • ZDWY.FSK.025

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Disease

Subscribe